About Accredo Pharma Science Private Limited
Data last updated:
Accredo Pharma Science Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 30 December 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U74900TN2011PLC083825. Its GSTIN is 33AAFCR6220B1ZZ (Tamil Nadu).
The company has an authorised share capital of ₹11 Cr and a paid-up capital of ₹1.96 Cr. It is led by directors including Jain Arihant Kumar Narendrakumar (Managing Director) and Subramanian Murali (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Chennai, Tamil Nadu.
As per the financials filed for FY 2025, the company reported a revenue of ₹43.12 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹1.44 Cr (net margin 3.3%) and EBITDA of ₹4.43 Cr (EBITDA margin 10.3%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 32% over five years.
The company has about 4 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹10 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website rsplindia.co.in.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressNew No. 14 Old No. 25/1, J Block, Chennai, Tamil Nadu, India – 600102
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Accredo Pharma Science Private Limited
The main business activity of Accredo Pharma Science is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Accredo Pharma Science Private Limited FY 2024 filings available
Accredo Pharma Science Private Limited reported revenue of ₹43.12 Cr (up 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Accredo Pharma Science Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 32% over five years, including 6% growth in the latest year. EBITDA rose 82% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Accredo Pharma Science Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹4.43 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.44 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Accredo Pharma Science Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 3.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Accredo Pharma Science are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Accredo Pharma Science Private Limited
Accredo Pharma Science Private Limited is compared with the companies closest to it by revenue in the Ecommerce and Internet industry (Healthcare Products). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Re'equil India Private Limited | ₹45.3 Cr (FY 2025) | •••• | •••• | 22.0% | •••• | Panchkula, Haryana, India |
| Khushboo Scientific Private Limited | ₹44.86 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Mumbai, Maharashtra, India |
| Chandan Pharmacy Limited | ₹44.47 Cr (FY 2022) | •••• | •••• | 55.0% | •••• | Lucknow, Uttar Pradesh, India |
| Claris Distribution Private Limited | ₹44.44 Cr (FY 2025) | •••• | •••• | 235.0% | •••• | Mumbai, Maharashtra, India |
| Getfast Pharmaceuticals Private Limited | ₹44.38 Cr (FY 2024) | •••• | •••• | -18.0% | •••• | Bangalore, Karnataka, India |
| Accredo Pharma Science Private Limited this company | ₹43.12 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Chennai, Tamil Nadu, India |
| Adven Biotech Private Limited | ₹42.97 Cr (FY 2024) | •••• | •••• | 8.0% | •••• | New Delhi, Delhi, India |
| Kosmochem Private Limited | ₹42.93 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Mumbai, Maharashtra, India |
| Medkart Pharmacy Private Limited | ₹41.58 Cr (FY 2024) | •••• | •••• | 16.0% | •••• | Ahmedabad, Gujarat, India |
| Sanrea Healthcare Products Private Limited | ₹40.01 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Palakkad, Kerala, India |
| Sheopals Private Limited | ₹38.41 Cr (FY 2024) | •••• | •••• | 60.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Accredo Pharma Science by revenue in the Ecommerce and Internet industry (Healthcare Products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Accredo Pharma Science Private Limited
Accredo Pharma Science has 7 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chittibabu Sarathchandran | Additional Director | 08 May 2015 | 11 Years 5 Months | Current |
| Jain Arihant Kumar Narendrakumar | Managing Director | 08 May 2015 | 11 Years 5 Months | Current |
| Subramanian Murali | Whole-Time Director | 11 Oct 2021 | 5 Years 0 Months | Current |
| Siroya Rajeshkumar | Director | 27 Mar 2018 | 8 Years 6 Months | Current |
| Soniya Jain | Additional Director | 16 Apr 2025 | 1 Years 5 Months | Current |
| Anil Sharma | Additional Director | 20 Nov 2025 | 0 Years 10 Months | Current |
Charges & Borrowings of Accredo Pharma Science Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Feb 2021 | Others | ₹10 Cr | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Accredo Pharma Science Private Limited
Employment history and EPFO contributions of people linked to Accredo Pharma Science.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Accredo Pharma Science Private Limited
Accredo Pharma Science has one previous CIN (Corporate Identification Number): U74900TN2011PTC083825. The current CIN is U74900TN2011PLC083825, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74900TN2011PLC083825 | Current |
| U74900TN2011PTC083825 | Previous |
Recent Activity on Accredo Pharma Science Private Limited
Accredo Pharma Science Private Limited has 17 board changes on record since 2014: 7 appointments and 10 cessations. The latest: Anil Sharma was appointed as Additional Director on 20 Nov 2025.
10 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Accredo Pharma Science Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Accredo Pharma Science Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Accredo Pharma Science Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Accredo Pharma Science Private Limited
Accredo Pharma Science has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAFCR6220B1ZZ | Tamil Nadu | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Accredo Pharma Science Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Accredo Pharma Science Private Limited
Accredo Pharma Science is an active private limited company based in Chennai, Tamil Nadu, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 30 December 2011 (15+ years old) and is registered under CIN U74900TN2011PLC083825.
Accredo Pharma Science reported revenue of ₹43.12 Cr for FY 2025 (up 6% YoY).
Accredo Pharma Science has 7 current directors:
- Jain Arihant Kumar Narendrakumar - Managing Director
- Subramanian Murali - Whole-Time Director
- Chittibabu Sarathchandran - Additional Director
- Siroya Rajeshkumar - Director
- Soniya Jain - Additional Director
- Anil Sharma - Additional Director
- Meenakshisundaram Kolandaivel - Additional Director
Accredo Pharma Science reported a net profit of ₹1.44 Cr (net margin 3.3%) and EBITDA of ₹4.43 Cr (EBITDA margin 10.3%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Accredo Pharma Science is 14% over three years and 32% over five years. In the latest year (FY 2025) revenue rose 6%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Accredo Pharma Science is 33AAFCR6220B1ZZ, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Accredo Pharma Science is U74900TN2011PLC083825. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Accredo Pharma Science was incorporated on 30 December 2011, making it 15+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Accredo Pharma Science by revenue are Re'equil India Private Limited, Khushboo Scientific Private Limited, Chandan Pharmacy Limited, Claris Distribution Private Limited, Getfast Pharmaceuticals Private Limited and 5 more, all in the Ecommerce and Internet industry (Healthcare Products).
Anil Sharma was appointed as Additional Director on 20 Nov 2025. Meenakshisundaram Kolandaivel was appointed as Additional Director on 20 Nov 2025. Soniya Jain ceased to be Additional Director on 06 Jul 2025. Accredo Pharma Science has 17 board changes on record in total.
Accredo Pharma Science can be reached through the website rsplindia.co.in. Its registered office is in Chennai, Tamil Nadu, India.